Sheng Xu

8PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)VirologyInnate immunityProteins and peptidesNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 28, 2025
SCRN1 confers hepatocellular carcinoma resistance to ferroptosis by stabilizing GPX4 via STK38-mediated phosphorylation.

Yijie Tao, Shulei Yin, Kai Wei

|Oct 07, 2024
Siglec-G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.

Shenhui Yin, Chunzhen Li, Xin Shen

|Sep 09, 2024
RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring.

Yunkai Zhang, Ying Gao, Yujia Wang

|Jun 17, 2024
Natural killer cells in cancer immunotherapy.

DanRu Wang, LingYun Dou, LiHao Sui

|Apr 07, 2024
The gasdermin family: emerging therapeutic targets in diseases.

Chenglong Zhu, Sheng Xu, Ruoyu Jiang

|Jan 13, 2024
Amino acid metabolism in tumor biology and therapy.

Jie Chen, Likun Cui, Shaoteng Lu

Pageof 2

Frequent Collaborators

4 joint publications

Yizhi Yu

2 joint publications

Zui Zou

1 joint publications

Feng Ma

1 joint publications

Xingguang Liu